Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

TARS

Tarsus Pharmaceuticals, Inc.

CIK 0001819790 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$64.14
↓ 3.59 (-5.30%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Options

Key stats

Market Cap
$2.76B
P/E Ratio
-57.18
EPS
-1.59
Dividend Yield
Not covered
52W Position
55%
Beta
0.63

Valuation multiples

Fwd P/E
106.38
PEG
Not covered
P/B
7.91
P/S
5.16
EV/Revenue
5.10
ROE
-13.8%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 55%
$38.51$85.25

Latest Financials

2025-12-31 FY
Revenue
$451.36M
Net Income
-$66.42M
Total Assets
$562.16M
Free Cash Flow
-$22.31M

Recent news